Clinical trial

Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)

NCT00278486 · Richard Burt, MD, Other · Terminated

Key facts

NCT number NCT00278486
Title Hematopoietic Stem Cell Transplantation in Autoimmune-Related Retinopathy(ARRON)
Official title Immune Ablation and Hematopoietic Stem Cell Transplantation in Patients With Autoimmune-Related Retinopathy and Optic Neuropathy (ARRON) Syndrome (Not Associated With Cancer)
Lead sponsor Richard Burt, MD, Other
Status Terminated
Phase Phase 1
Study type Interventional
Conditions Retinal Disease
Intervention type Biological
Interventions Hematopoietic stem cell transplantation.
Enrollment 2
Start date Aug 1, 2004
Primary completion Apr 1, 2012
Completion Apr 1, 2012
First posted Jan 18, 2006
Last update posted Apr 8, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies